Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysis
- PMID: 31507240
- DOI: 10.1177/1724600819874487
Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysis
Abstract
Background: Preoperative estimation of microvascular invasion is of great significance for the clinical decision making in hepatocellular carcinoma. Neutrophil-lymphocyte ratio (NLR) has been reported to be correlated with the poor prognosis of hepatocellular carcinoma. However, the conclusions are conflicting on whether high preoperative NLR level is associated with the presence of microvascular invasion.
Aim: To evaluate the association between preoperative NLR level and the risk of microvascular invasion in hepatocellular carcinoma.
Methods: Relevant studies were identified by searching PubMed and Embase through February 2019. Fixed or random models were applied to analyze the data based on the heterogeneity. Subgroup, sensitivity, and publication bias analyses were performed. Review Manager 5.3 and STATA software were used for the meta-analysis.
Results: A total of 15 studies were eventually included in this meta-analysis. Pooled data based on retrospective cohort studies showed there are more hepatocellular carcinoma patients with vascular invasion (OR 1.74; 95% Cl 1.42, 2.12; P < 0.001) and microvascular invasion (OR 1.62 95% Cl 1.39, 1.89; P < 0.001) in the high NLR group than in the low NLR group. Of case-control studies, a higher preoperative NLR level was found in the microvascular invasion positive group than in the microvascular invasion negative group (OR 0.62; 95% Cl 0.35, 0.90; P < 0.001). The subgroup, sensitivity, and publication bias analyses did not change the results.
Conclusion: A higher preoperative NLR level is positively correlated with the risk of microvascular invasion in hepatocellular carcinoma.
Keywords: HCC; MVI; NLR; meta-analysis.
Similar articles
-
Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis.Front Immunol. 2023 Sep 21;14:1211399. doi: 10.3389/fimmu.2023.1211399. eCollection 2023. Front Immunol. 2023. PMID: 37809083 Free PMC article.
-
Prognostic value of neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma receiving curative therapies: a systematic review and meta-analysis.BMC Cancer. 2025 Mar 29;25(1):571. doi: 10.1186/s12885-025-13972-w. BMC Cancer. 2025. PMID: 40158082 Free PMC article.
-
Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.Oncotarget. 2016 Nov 1;7(44):72276-72289. doi: 10.18632/oncotarget.10848. Oncotarget. 2016. PMID: 27472390 Free PMC article.
-
Using Pre-Treatment Neutrophil-to-Lymphocyte Ratio to Predict the Prognosis of Young Patients with Hepatocellular Carcinoma Implemented Minimally Invasive Treatment.J Adolesc Young Adult Oncol. 2020 Feb;9(1):85-89. doi: 10.1089/jayao.2019.0046. Epub 2019 Oct 17. J Adolesc Young Adult Oncol. 2020. PMID: 31621472
-
Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis.World J Gastroenterol. 2016 Jun 7;22(21):5088-95. doi: 10.3748/wjg.v22.i21.5088. World J Gastroenterol. 2016. PMID: 27275101 Free PMC article.
Cited by
-
Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study.BMC Med Imaging. 2021 Mar 5;21(1):40. doi: 10.1186/s12880-021-00572-w. BMC Med Imaging. 2021. PMID: 33673821 Free PMC article.
-
The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.Med Sci Monit. 2020 Jan 13;26:e918824. doi: 10.12659/MSM.918824. Med Sci Monit. 2020. PMID: 31929496 Free PMC article.
-
Significant association between high neutrophil-lymphocyte ratio and poor prognosis in patients with hepatocellular carcinoma: a systematic review and meta-analysis.Front Immunol. 2023 Sep 21;14:1211399. doi: 10.3389/fimmu.2023.1211399. eCollection 2023. Front Immunol. 2023. PMID: 37809083 Free PMC article.
-
Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.J Cancer Res Clin Oncol. 2021 Dec;147(12):3757-3767. doi: 10.1007/s00432-021-03617-3. Epub 2021 Apr 10. J Cancer Res Clin Oncol. 2021. PMID: 33839938 Free PMC article.
-
Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221144510. doi: 10.1177/15330338221144510. Technol Cancer Res Treat. 2022. PMID: 36573042 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical